Qingdao Hongshengda TradingTirzepatide
Ordered Tirzepatide from Qingdao Hongshengda Trading? Mail in a sample (US only) and let us test it for free.
Test my supplyThe key drag is a failed-identity result with 0% purity and 0 mg found for batch 07152025, despite a later same-batch-ID pass at 99.8% with +18% fill. Evidence is mixed, with an early no-batch test and no price/review corroboration.
We investigated who actually operates Qingdao Hongshengda Trading — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Qingdao Hongshengda Trading rows.
Cancel anytime
About Qingdao Hongshengda Trading test results from Finnrick
Qingdao Hongshengda Trading is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 7 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Qingdao Hongshengda Trading peptides in this dataset are Retatrutide (3 tests) and Tirzepatide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 7 recent tests.
Ordered Tirzepatide from Qingdao Hongshengda Trading? Mail in a sample (US only) and let us test it for free.
Test my supply